Rosiglitazone/metformin
At a glance
- Drug Originator GlaxoSmithKline
- Drug Licenced by Glenmark Pharmaceuticals Ltd
- Drug Class Antihyperglycaemics; Biguanides; Insulin sensitisers; Thiazolidinediones
- Mechanism of Action AMP activated protein kinase stimulants; Peroxisome proliferator-activated receptor gamma agonists
- USA Patent Applicants SB PHARMCO
- USA Patents 7
- NDAs 1
- Patent Applications 2,652
Table of Contents

Disclaimer